Search - tctmd.com

Displaying 61 - 80 of 191

Sort: Relevancy | Date

Presentation TCT 2019

Contemporary Antiplatelet/Anticoagulation Therapy Post-PCI

Presenter: Sorin Brener

September 25, 2019

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation TVT 2019

Indications for LAA Closure: Defining Relative Contraindications to Anticoagulation

Presenter: David Holmes Jr.

June 13, 2019

Presentation

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

April 18, 2019

Presentation ARCH 2019

Femoral Access-Basics

Presenter: Howard Kurz

April 10, 2019

Presentation SIF 2019

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Presenter: Michael A. Kutcher

March 29, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation JIM 2019

How to select a NOAC: a simple guide for the busy interventionist

Presenter: Roberta Rossini

February 14, 2019

Presentation LINC 2019

What Are the Current Recommendations for “Optimal Medical Therapy”

Presenter: Daniella Kadian-Dodov

January 25, 2019

Presentation

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

January 09, 2019

Presentation TCT 2018

Choice and Duration of Antiplatelet and Anticoagulation Therapy After Venous Interventions (With Case Reviews)

Presenter: Brian G. DeRubertis, Mahmood K. Razavi, Anthony J. Comerota

September 24, 2018

Presentation TCT 2018

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Presenter: Gregg W. Stone, Yukiko Nakano

September 24, 2018

Presentation TCT 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne

September 23, 2018

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt

September 23, 2018

Presentation TCT 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson

September 23, 2018

Presentation TCT 2018

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

Presenter: Davide Capodanno, Giulio Stefanini, Tullio Palmerini

September 23, 2018

Presentation TCT 2018

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

Presenter: Martina Kelly Speight, Patricia Keegan

September 23, 2018

Presentation TCT 2018

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Presenter: Walter Desmet, Guy J. Friedrich, Oleg Polonetsky

September 22, 2018

Presentation TCT 2018

Bleeding Risk and Management Strategies in Elderly Patients on Chronic Oral Anticoagulation

Presenter: Walter Desmet, Guy J. Friedrich, Kurt Huber

September 22, 2018

Advertisement

Contemporary Antiplatelet/Anticoagulation Therapy Post-PCI

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Indications for LAA Closure: Defining Relative Contraindications to Anticoagulation

Safety and Efficacy of TAVR With Continuation of Oral Anticoagulation

Femoral Access-Basics

DEBATE:What is the Optimal Choice for Post PCI Patients Requiring Chronic Anticoaguation :Triple Therapy

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

How to select a NOAC: a simple guide for the busy interventionist

What Are the Current Recommendations for “Optimal Medical Therapy”

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

Choice and Duration of Antiplatelet and Anticoagulation Therapy After Venous Interventions (With Case Reviews)

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Bleeding Risk and Management Strategies in Elderly Patients on Chronic Oral Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content